iShares Global Healthcare ETF (NYSEARCA:IXJ) Sees Large Volume Increase – Here’s What Happened

iShares Global Healthcare ETF (NYSEARCA:IXJ) shares saw an uptick in trading volume on Friday . 827,727 shares were traded during trading, an increase of 197% from the previous session’s volume of 278,815 shares.The stock last traded at $98.72 and had previously closed at $96.86.

iShares Global Healthcare ETF Price Performance

The business’s 50 day simple moving average is $93.84 and its 200 day simple moving average is $96.16. The company has a market capitalization of $3.85 billion, a PE ratio of 21.58 and a beta of 0.58.

Institutional Trading of iShares Global Healthcare ETF

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. LOM Asset Management Ltd acquired a new position in iShares Global Healthcare ETF in the third quarter valued at approximately $26,000. Nvest Wealth Strategies Inc. purchased a new position in iShares Global Healthcare ETF during the 4th quarter valued at about $30,000. Franklin Resources Inc. boosted its stake in shares of iShares Global Healthcare ETF by 80.0% in the second quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock valued at $31,000 after purchasing an additional 160 shares during the period. Arax Advisory Partners purchased a new position in iShares Global Healthcare ETF in the 4th quarter valued at approximately $31,000. Finally, Capital Investment Counsel Inc purchased a new position in iShares Global Healthcare ETF in the 4th quarter valued at approximately $42,000.

About iShares Global Healthcare ETF

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.